An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

Microplastics have now been found inside most prostate cancer tumors — and at strikingly higher levels than in healthy tissue.

Researchers at NYU Langone Health have detected tiny plastic fragments in nine out of 10 prostate cancer tumors examined, a ...

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

Experts recommend regular screening to increase the chance of detecting prostate cancer early, when it is most treatable. (Dreamstime/TCA) Prostate cancer is one of the most common cancers in the ...

Small fragments of plastic were found in 9 out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds. The small, single-center ...

Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in prostate cancer risk. About 1 in ...

A drug for advanced prostate cancer has shown "remarkable" results in an early-stage trial, experts have said.

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.